Aminoglutethimide

From Wikipedia, the free encyclopedia

Aminoglutethimide
Systematic (IUPAC) name
3-(4-aminophenyl)-3-ethyl-piperidine-2,6-dione
Identifiers
CAS number 125-84-8
ATC code L02BG01
PubChem 2145
DrugBank APRD00592
Chemical data
Formula C13H16N2O2 
Mol. mass 232.278 g/mol
Pharmacokinetic data
Bioavailability >95%
Metabolism Hepatic
Half life 12.5 ± 1.6 hours
Excretion Renal
Therapeutic considerations
Pregnancy cat.

D: (USA)
D:(AUS)

Legal status
Routes Oral

Aminoglutethimide blocks the conversion of cholesterol to pregnenolone by inhibiting the enzyme desmolase, thus inhibits synthesis of all hormonally active steroids. It can be used in conjunction with other drugs for treatment of steroid-producing adrenocortical cancer.

Its major side effects are liver toxicity, inhibition of cortisol in the human body, and it may also cause hypothyroidism. Since cortisol helps break down muscle, aminoglutethimide is used by bodybuilders in a steroid cycle.

It is still used to suppress corticosteroid production in Cushing's Syndrome.

It is marketed under the tradename Cytadren.

[edit] Clinical uses

Aminoglutethimide is indicated for the suppression of adrenal function in selected patients with Cushing's syndrome.

[edit] External links

[edit] See also


Languages